IN THE UNITED STATES BANKRUPTCY COURT

FOR THE NORTHERN DISTRICT OF TEXAS

DALLAS DIVISION

In re:

EIGER BIOPHARMACEUTICALS, INC., et 

al.1

 Debtors.

Chapter 11

Case No. 24-80040 (SGJ)

(Jointly Administered)

SCHEDULES OF ASSETS AND LIABILITIES OF

DEBTOR EIGER BIOPHARMACEUTICALS EUROPE LIMITED (CASE NO. 24-80043)

1 The Debtors in these chapter 11 cases, together with the last four digits of each Debtor’s federal tax 

identification number, are: Eiger BioPharmaceuticals, Inc. (1591); EBPI Merger Inc. (9986); EB Pharma LLC 

(8352); Eiger BioPharmaceuticals Europe Limited (N/A); and EigerBio Europe Limited (N/A). The Debtors’ 

service address is 2100 Ross Avenue, Dallas, Texas 75201.

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 1 of 34
IN THE UNITED STATES BANKRUPTCY COURT

FOR THE NORTHERN DISTRICT OF TEXAS

DALLAS DIVISION

In re:

EIGER BIOPHARMACEUTICALS, INC., et 

al.1

 Debtors. 

Chapter 11 

Case No. 24-80040 (SGJ) 

(Jointly Administered)

GLOBAL NOTES AND STATEMENT OF LIMITATIONS, 

METHODOLOGY, AND DISCLAIMERS REGARDING THE DEBTORS’ SCHEDULES 

OF ASSETS AND LIABILITIES AND STATEMENTS OF FINANCIAL AFFAIRS

On April 1, 2024 (the “Petition Date”), Eiger BioPharmaceuticals, Inc. and its affiliated 

debtors in the above-captioned chapter 11 cases (each a “Debtor” and, collectively, the “Debtors”) 

commenced voluntary cases (the “Chapter 11 Cases”) under chapter 11 of title 11, United States 

Code, §§ 101 et seq. (the “Bankruptcy Code”) in the United States Bankruptcy Court for the 

Northern District of Texas (the “Court”). 

The Debtors continue to operate their businesses and manage their properties as debtors 

and debtors in possession, pursuant to sections 1107(a) and 1108 of the Bankruptcy Code. The 

Chapter 11 Cases have been consolidated for procedural purposes only and are being jointly 

administered under case number 24-80040 (SGJ). 

The Schedules of Assets and Liabilities (the “Schedules”) and Statements of Financial 

Affairs (the “Statements”) were prepared pursuant to section 521 of the Bankruptcy Code and 

Rule 1007 of the Federal Rules of Bankruptcy Procedure (the “Bankruptcy Rules”) by 

management of the Debtors with unaudited information available as of the Petition Date. 

These Global Notes and Statement of Limitations, Methodology, and Disclaimers 

Regarding the Debtors’ Schedules and Statements of Financial Affairs (the “Global Notes”) are 

incorporated by reference in, and comprise an integral part of, each Debtor’s respective Schedules 

and Statements, and should be referred to and considered in connection with any review of the 

Schedules and Statements.

In preparing the Schedules and Statements, the Debtors relied on financial data derived 

from their books and records that was available at the time of such preparation. The Debtors, and 

1 The Debtors in these chapter 11 cases, together with the last four digits of each Debtor’s federal tax identification 

number, are: Eiger BioPharmaceuticals, Inc. (1591); EBPI Merger Inc. (9986); EB Pharma LLC (8352); Eiger 

BioPharmaceuticals Europe Limited (N/A); and EigerBio Europe Limited (N/A). The Debtors’ service address 

is 2100 Ross Avenue, Dallas, Texas 75201. 

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 2 of 34
2

their agents, attorneys, and advisors do not guarantee or warrant the accuracy or completeness of 

the data that is provided herein, and shall not be liable for any loss or injury arising out of or caused 

in whole or in part by the acts, errors, or omissions, whether negligent or otherwise, in procuring, 

compiling, collecting, interpreting, reporting, communicating, or delivering the information 

contained herein. While reasonable efforts have been made to provide accurate and complete 

information herein, inadvertent errors or omissions may exist. The Debtors reserve their rights to 

amend and supplement the Schedules and Statements as may be necessary or appropriate. For the 

avoidance of doubt, the Debtors and their agents, attorneys, and advisors expressly do not 

undertake any obligation to update, modify, revise, or re-categorize the information provided 

herein, or to notify any third party should the information be updated, modified, revised, or 

re-categorized, except as required by applicable law. In no event shall the Debtors, or their agents, 

attorneys, and advisors, be liable to any third party for any direct, indirect, incidental, 

consequential, or special damages (including, but not limited to, damages arising from the 

disallowance of a potential claim against the Debtors or damages to business reputation, lost 

business, or lost profits), whether foreseeable or not and however caused, even if the Debtors or 

their agents, attorneys, or advisors are advised of the possibility of such damages. 

Given, among other things, the uncertainty surrounding the valuation and nature of certain 

assets and liabilities, to the extent that a Debtor shows more assets than liabilities, this is not an 

admission that such Debtor was solvent on the Petition Date or at any time prior to the Petition 

Date. Likewise, to the extent that a Debtor shows more liabilities than assets, it is not an admission 

that such Debtor was insolvent on the Petition Date or any time prior to the Petition Date. 

Douglas Staut has signed each set of the Schedules and Statements. Mr. Staut serves as 

the Chief Restructuring Officer (“CRO”) of the Debtors, and he is an authorized signatory for each 

of the Debtors in these Chapter 11 Cases. In reviewing and signing the Schedules and Statements, 

Mr. Staut has necessarily relied upon the efforts, statements, advice, and representations of the 

Debtors and their advisors. Mr. Staut has not (and could not have) personally verified the accuracy 

of each such statement and representation, including statements and representations concerning 

amounts owed to creditors, classification of such amounts, and creditor addresses. 

Global Notes and Overview of Methodology 

1. In the ordinary course of business, the Debtors routinely engage in intercompany 

transactions (collectively, the “Intercompany Transactions”) with one another, which result in 

intercompany receivables and payables (collectively, the “Intercompany Claims”). Intercompany 

Transactions and Intercompany Claims arise from relationships and historical practice, or certain 

intercompany agreements and intercompany loans (collectively, the “Intercompany Relationships” 

or “Intercompany Agreements”) to support operations and shared service functions, including 

product development services, software sales, software licensing, provision of management 

services, revenue sharing arrangements, back-office support transactions and intercompany loan 

and interest payments. The Debtors manually track and allocate receivables and payables across 

the corporate enterprise. 

2. EB Pharma LLC. EB Pharma LLC (“EB Pharma”) is a wholly-owned subsidiary 

of Eiger BioPharmaceuticals, Inc. (“Eiger”), which is the primary operating entity. EB Pharma 

had no operations in the year prior to the Petition Date other than tax filings. EB Pharma has no 

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 3 of 34
3

sales receipts. All vendors supporting its tax filings are paid by Eiger. Accordingly, the Debtors 

have reported the only assets owned by EB Pharma, which includes licenses and interests in 

insurance policies. The Debtors reserve all rights to amend and supplement the Schedules and 

Statements as may be necessary or appropriate.

3. Eiger BioPharmaceuticals Europe Limited. Eiger BioPharmaceuticals Europe 

Limited (“Eiger BioPharmaceuticals Europe”) is a wholly-owned subsidiary of Eiger. Eiger 

BioPharmaceuticals Europe had no operations in the year prior to the Petition Date other than tax 

filings. Eiger BioPharmaceuticals Europe has no sales receipts. All vendors supporting its tax 

filings are paid by Eiger. The Debtors reserve all rights to amend and supplement the Schedules 

and Statements as may be necessary or appropriate.

4. EBPI Merger Inc. EBPI Merger Inc. (“EBPI Merger”) is a wholly-owned 

subsidiary of Eiger. EBPI Merger had no operations in the year prior to the Petition Date other 

than tax filings. EBPI Merger has no sales receipts. Tax liabilities for EBPI Merger are paid 

through Eiger’s operating accounts. Accordingly, the Debtors have reported the only assets owned 

by EBPI Merger, which includes intellectual property and interests in insurance policies or 

annuities. The Debtors reserve all rights to amend and supplement the Schedules and Statements 

as may be necessary or appropriate. 

5. EigerBio Europe Limited. EigerBio Europe Limited (“EigerBio Europe”) is a 

wholly-owned subsidiary of Eiger. EigerBio Europe incurs rent and other operating expenses. 

Cash collections from any sales in Germany are deposited into EigerBio Europe’s bank account. 

The Debtors have reported the assets owned by EigerBio Europe. The Debtors reserve all rights 

to amend and supplement the Schedules and Statements as may be necessary or appropriate.

6. Reservations and Limitations. Reasonable efforts have been made to prepare and 

file complete and accurate Schedules and Statements; however, as noted above, inadvertent errors 

or omissions may exist. The Debtors reserve all rights to amend and supplement the Schedules 

and Statements as may be necessary or appropriate. Nothing contained in the Schedules and 

Statements constitutes a waiver of any of the Debtors’ rights or an admission of any kind with 

respect to these Chapter 11 Cases, including, but not limited to, any rights or claims of the Debtors 

against any third party or issues involving substantive consolidation, equitable subordination, or 

defenses or causes of action arising under the provisions of chapter 5 of the Bankruptcy Code or 

any other relevant applicable bankruptcy or non-bankruptcy laws to recover assets or avoid 

transfers. Any specific reservation of rights contained elsewhere in the Global Notes does not 

limit in any respect the general reservation of rights contained in this paragraph. 

(a) No Admission. Nothing contained in the Schedules and Statements is intended or 

should be construed as an admission or stipulation of the validity of any claim 

against the Debtors, any assertion made therein or herein, or a waiver of the 

Debtors’ rights to dispute any claim or assert any cause of action or defense against 

any party.

(b) Recharacterization. Notwithstanding that the Debtors have made reasonable

efforts to correctly characterize, classify, categorize, or designate certain claims, 

assets, executory contracts, unexpired leases, and other items reported in the 

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 4 of 34
4

Schedules and Statements, the Debtors nonetheless may have improperly 

characterized, classified, categorized, or designated certain items. The Debtors 

reserve all rights to recharacterize, reclassify, recategorize, or redesignate items 

reported in the Schedules and Statements at a later time as is necessary and 

appropriate, including, without limitation, whether contracts or leases listed herein 

were deemed executory or unexpired as of the Petition Date and remain executory 

and unexpired post-petition. Disclosure of information in one or more Schedules, 

Statements, or one or more exhibits or attachments thereto, even if incorrectly 

placed, shall be deemed to be disclosed in the correct Schedules, Statements, 

exhibits, or attachments.

(c) Classifications. Listing (i) a claim on Schedule D as “secured,” (ii) a claim on 

Schedule E/F as “priority” or “unsecured,” or (iii) a contract on Schedule G as 

“executory” or “unexpired” does not constitute an admission by the Debtors of the 

legal rights of the claimant or contract counterparty, or a waiver of the Debtors’ 

rights to recharacterize or reclassify such claim or contract or to setoff such claim.

(d) Claims Description. Any failure to designate a claim on the Debtors’ Schedules 

and Statements as “disputed,” “contingent,” or “unliquidated” does not constitute 

an admission by the Debtors that such amount is not “disputed,” “contingent,” or 

“unliquidated.” Each Debtor reserves all rights to dispute, or assert offsets or 

defenses to, any claim reflected on its respective Schedules and Statements on any 

grounds, including, without limitation, liability, or classification, or to otherwise 

subsequently designate such claims as “disputed,” “contingent,” or “unliquidated” 

or object to the extent, validity, enforceability, or priority of any claim. Moreover, 

listing a claim does not constitute an admission of liability by the Debtors against 

which the claim is listed or by any of the Debtors. The Debtors reserve all rights 

to amend their Schedules and Statements as necessary and appropriate, including, 

but not limited to, with respect to claim description and designation. 

(e) Estimates and Assumptions. The preparation of the Schedules and Statements 

required the Debtors to make reasonable estimates and assumptions with respect to 

the reported amounts of assets and liabilities, the amount of contingent assets and 

contingent liabilities on the Schedules and Statements, and the reported amounts of 

revenues and expenses during the applicable reporting periods. Actual results could 

differ from such estimates.

(f) Causes of Action. Despite reasonable efforts, the Debtors may not have identified 

all current and potential causes of action the Debtors may have against third parties 

in their respective Schedules and Statements, including, without limitation, 

avoidance actions arising under chapter 5 of the Bankruptcy Code and actions under 

other relevant bankruptcy and non-bankruptcy laws to recover assets. The Debtors 

reserve all rights with respect to any causes of action, and nothing in these Global 

Notes or the Schedules and Statements should be construed as a waiver of any such 

causes of action. 

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 5 of 34
5

(g) Intellectual Property Rights. Exclusion of certain intellectual property from the 

Schedules and Statements should not be construed as an admission that such 

intellectual property rights have been abandoned, have been terminated or 

otherwise expired by their terms, or have been assigned or otherwise transferred 

pursuant to a sale, acquisition, or other transaction. Conversely, inclusion of certain 

intellectual property rights in the Schedules and Statements should not be construed 

as an admission that such intellectual property rights have not been abandoned, 

have not been terminated or otherwise expired by their terms, or have not been 

assigned or otherwise transferred pursuant to a sale, acquisition, or other 

transaction. 

(h) Executory Contracts and Unexpired Leases. Although the Debtors made 

diligent efforts to identify contracts and unexpired leases as executory within the 

scope of section 365 of the Bankruptcy Code and to attribute an executory contract 

to its rightful Debtors, in certain instances, the Debtors may have inadvertently 

failed to do so due to the complexity and size of the Debtors’ businesses. 

Accordingly, the Debtors reserve all of their rights with respect to the inclusion or 

exclusion of executory contracts and unexpired leases, as well as the named parties

to any and all executory contracts and unexpired leases, including the right to 

amend Schedule G at any time during the pendency of these Chapter 11 Cases.

(i) Insiders. In the circumstance where the Schedules and Statements require 

information regarding “insiders,” the Debtors have included information with 

respect to certain individuals who served as officers and directors, as the case may 

be, during the relevant time periods. Such individuals may no longer serve in such 

capacities. 

The listing or omission of a party as an insider for purposes of the Schedules and

Statements is not intended to be, nor should it be, construed as an admission of any 

fact, right, claim, or defense and all such rights, claims, and defenses are hereby 

expressly reserved. Information regarding the individuals listed as insiders in the 

Schedules and Statements has been included for informational purposes only and 

such information may not be used for: (i) the purposes of determining (A) control 

of the Debtors; (B) the extent to which any individual exercised management 

responsibilities or functions; (C) corporate decision-making authority over the 

Debtors; or (D) whether such individual could successfully argue that he or she is 

not an insider under applicable law, including the Bankruptcy Code and federal 

securities laws, or with respect to any theories of liability or (ii) any other purpose.

7. Description of Cases and “As Of” Information Date. On April 1, 2024, or the Petition 

Date, each of the Debtors filed a voluntary petition for relief under chapter 11 of the 

Bankruptcy Code in the Court. The Debtors continue to operate their business. The 

information provided herein, except as otherwise noted, is reported as of the Petition Date 

of each respective Debtor, as appropriate.

8. Methodology. 

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 6 of 34
6

(a) Basis of Presentation. The Schedules and Statements do not purport to represent 

financial statements prepared in accordance with Generally Accepted Accounting 

Principles in the United States (“GAAP”) nor are they intended to be fully 

reconciled to the financial statements of each Debtor. The Schedules and 

Statements contain unaudited information that is subject to further review and 

potential adjustment. The Schedules and Statements reflect the Debtors’ 

reasonable efforts to report the assets and liabilities of each Debtor on an 

unconsolidated basis.

(b) Duplication. Certain of the Debtors’ assets, liabilities, and prepetition payments 

may properly be disclosed in multiple parts of the Statements and Schedules. To 

the extent these disclosures would be duplicative, the Debtors have endeavored to 

only list such assets, liabilities, and prepetition payments once.

(c) Net Book Value. In certain instances, current market valuations for individual 

items of property and other assets are neither maintained by, nor readily available 

to the Debtors. Accordingly, unless otherwise indicated, the Debtors’ Schedules 

and Statements reflect net book values as of the Petition Date. Market values may 

vary, in some instances, materially, from net book values. The Debtors believe that 

it would be an inefficient use of estate assets for the Debtors to obtain the current 

market values of their property. Accordingly, the Debtors have indicated in the 

Schedules and Statements that the market values of certain assets and liabilities are 

undetermined. Also, assets that have been fully depreciated or that were expensed 

for accounting purposes either do not appear in these Schedules and Statements, or 

are listed with a zero-dollar value, as such assets have no net book value. The 

omission of an asset from the Schedules and Statements does not constitute a 

representation regarding the ownership of such asset, and any such omission does 

not constitute a waiver of any rights of the Debtors with respect to such asset. 

(d) Undetermined Amounts. The description of an amount as “unknown,” “TBD,” 

or “undetermined” is not intended to reflect upon the materiality of such amount. 

(e) Unliquidated Amounts. Amounts that could not be fairly quantified by the 

Debtors are scheduled as “unliquidated.” 

(f) Totals. All totals that are included in the Schedules and Statements represent totals 

of all known amounts. To the extent there are unknown or undetermined amounts, 

the actual total may be different from the listed total.

(g) Paid Claims. The Debtors have authority to pay certain outstanding prepetition 

payables pursuant to various orders entered by the Court. The Debtors scheduled 

such amounts as of the Petition Date and noted such amounts as contingent. To the 

extent the Debtors later pay any amount of the claims listed in the Schedules and 

Statements pursuant to any orders entered by the Court, the Debtors reserve all 

rights to amend or supplement the Schedules and Statements or to take other action, 

such as filing claims objections, as is necessary and appropriate to avoid 

overpayment or duplicate payments for liabilities. Nothing contained herein should 

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 7 of 34
7

be deemed to alter the rights of any party in interest to contest a payment made 

pursuant to an order of the Court where such order preserves the right to contest.

(h) Liens. The inventories, property, and equipment listed in the Schedules and 

Statements are presented without consideration of any liens.

(i) Currency. Unless otherwise indicated, all amounts are reflected in U.S. dollars.

Some bank accounts in EigerBio Europe may be held in Euro but converted to the 

U.S. Dollar equivalent as of the Petition Date. 

(j) Liabilities. The Debtors have sought to allocate liabilities between the prepetition 

and postpetition periods based on the information and research conducted in 

connection with the preparation of the Schedules and Statements. As additional 

information becomes available and further research is conducted, the allocation of 

liabilities between the prepetition and postpetition periods may change. The 

Debtors reserve the right to amend the Schedules and Statements as they deem 

appropriate in this and all other regards.

(k) Excluded Assets and Liabilities. The Debtors have excluded certain categories of 

assets and liabilities from the Schedules and Statements, including, but not limited 

to: certain deferred charges, investments in subsidiaries, reserves recorded only for 

purposes of complying with the requirements of GAAP, and deferred tax assets,

and deferred tax liabilities. The Debtors have also excluded rejection damage 

claims of counterparties to executory contracts and unexpired leases that may or 

may not be rejected, to the extent such damage claims exist. Other immaterial 

assets and liabilities may also have been excluded. 

(l) Credits and Adjustments. The claims of individual creditors for, among other 

things, goods, products, services, or taxes are listed as the amounts entered on the 

Debtors’ books and records and may either (i) not reflect credits, allowances, or 

other adjustments due from such creditors to the Debtors or (ii) be net of accrued 

credits, allowances, or other adjustments that are actually owed by a creditor to the 

Debtors on a postpetition basis on account of such credits, allowances, or other 

adjustments earned from prepetition payments and critical vendor payments, if 

applicable. The Debtors reserve all of their rights with regard to such credits, 

allowances, or other adjustments, including, but not limited to, the right to modify 

the Schedules, assert claims objections and/or setoffs with respect to the same, or 

apply such allowances in the ordinary course of business on a postpetition basis.

(m) Setoffs. The Debtors may periodically incur setoffs and net payments in the 

ordinary course of business. Such setoffs and nettings may occur due to a variety 

of transactions or disputes. Although such setoffs and other similar rights may have 

been accounted for when scheduling certain amounts, these ordinary course setoffs 

are not independently accounted for, and as such, are or may be excluded from the 

Debtors’ Schedules and Statements. The Debtors reserve all rights to challenge any 

setoff and/or recoupment rights that may be asserted.

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 8 of 34
8

9. Global Notes Control. These Global Notes pertain to and comprise an integral part of 

each of the Schedules and Statements and should be referenced in connection with any 

review thereof. In the event that the Schedules and Statements conflict with these Global 

Notes, these Global Notes shall control. 

10. Specific Schedules Disclosures.

(a) Schedules Summary. Except as otherwise noted, the asset totals represent 

amounts as of the Petition Date and liability information provided herein represents 

the Debtors’ liabilities as of the Petition Date.

(b) Schedule A/B, Part 4 – Investments; Non-Publicly Traded Stock and Interests 

in Incorporated and Unincorporated Businesses, including any Interest in an 

LLC, Partnership, or Joint Venture. Eiger’s ownership interests in subsidiaries 

have been listed in Schedule A/B, Part 4, as undetermined amounts on account of 

the fact that the fair market value of such ownership is dependent on numerous 

variables and factors, and may differ significantly from their net book value. 

(c) Schedule A/B, Part 5 – Inventory. The Debtors’ products have three- or fouryear shelf lives. The Debtors’ inventory is managed by third parties. 

(d) Schedule A/B, Part 7 – Office furniture, fixtures, and equipment; and 

collectibles. The Debtors have used book values as of April 1, 2024 for reporting 

office furniture and equipment. There have been no valuations on any of such 

assets. These amounts may include leasehold improvements. The Debtors reserve 

all of their rights to re-categorize and/or re-characterize such asset holdings to the 

extent the Debtors determine that such holdings were improperly listed.

(e) Schedule A/B, Part 9 – Real Property. The Debtors lease all of their real 

properties and, as such, the leased properties’ value have been marked as 

undetermined. Furthermore, certain of the property leases reflected on Schedule 

A/B 55 may contain renewal options, guarantees of payment, options to purchase, 

rights of first refusal, rights to lease additional lands, and other miscellaneous 

rights. Such rights, powers, duties, and obligations are not separately set forth on 

Schedule A/B 55. The Debtors hereby expressly reserve the right to assert that any 

instrument listed on Schedule A/B 55 is an executory contract or unexpired lease 

within the meaning of section 365 of the Bankruptcy Code. The Debtors reserve 

all of their rights, claims, and causes of action with respect to claims associated 

with any contracts and agreements listed on Schedule A/B 55, including their right 

to dispute or challenge the characterization or the structure of any transaction, 

document, or instrument, including any intercompany agreement. 

(f) Schedule A/B, Part 10 – Intangibles and Intellectual Property. The value of the 

Debtors’ intangible assets is listed as undetermined. The Debtors are not able to 

provide a schedule with values specific to its intellectual property (including but 

not limited to, patents, trademarks, internet domains, and licenses).

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 9 of 34
9

(g) Schedule A/B, Part 11 – All Other Assets. Eiger has incurred significant net 

operating losses (“NOLs”) and research and development credits (“R&D Credits”)

(together, the “Tax Attributes”) since itsinception. As of December 31, 2023, Eiger

has generated federal NOLs of $322.5 million. The Debtors also has $47.1 million 

of state NOLs, $15.5 million of federal orphan drug tax credits, $4.0 million of state 

R&D Credits and $1.6 million of federal R&D Credits. Further, the Debtors 

estimate that they may generate additional Tax Attributes in the 2024 tax year. 

Such Tax Attributes have not been valued as of the Petition Date and may be 

restricted in their use. 

(h) Schedule D – Creditors Who Have Claims Secured by Property. The Debtors 

have made reasonable efforts to report all secured claims against the Debtors on 

Schedule D based on the Debtors’ books and records as of the Petition Date. 

However, the actual value of claims against the Debtors may vary significantly 

from the represented liabilities. Parties in interest should not accept that the listed 

liabilities necessarily reflect the correct amount of any secured creditor’s allowed 

claims or the correct amount of all secured claims. Similarly, parties in interest 

should not anticipate that recoveries in these cases will reflect the relationship of 

the aggregate asset values and aggregate liabilities set forth in the Schedules. 

Parties in interest should consult their own professionals and advisors with respect 

to pursuing a claim. Although the Debtors and their professionals have generated 

financial information and data the Debtors believe to be reasonable, actual 

liabilities (and assets) may deviate significantly from the Schedules due to certain 

events that occur throughout these Chapter 11 Cases. 

Except as specifically stated herein, lessors of real property and equipment, utility 

companies, and any other parties which may hold security deposits or other security 

interests, have not been listed on Schedule D. The Debtors have also not listed on 

Schedule D any parties whose claims may be secured through rights of setoff, 

deposits, or advance payments. 

Although the Debtors may have scheduled claims of various creditors as secured 

claims, the Debtors reserve all rights to dispute or challenge the secured nature of 

any creditor’s claim or the characterization of the structure of any transaction or 

any document or instrument (including, without limitation, any intercompany 

agreement) related to such creditor’s claim (except as otherwise agreed to or stated 

pursuant to a stipulation, agreed order, or general order entered by the Bankruptcy 

Court that is or becomes final). The Debtors have not included on Schedule D the 

claims of any parties that may believe their claims are secured through setoff rights 

or inchoate statutory lien rights. 

The descriptions provided on Schedule D are intended only as a summary. 

Reference to the applicable loan agreements and related documents is necessary for 

a complete description of the collateral and the nature, extent, and priority of any 

liens. Nothing in these Global Notes or in the Schedules and Statements shall be 

deemed a modification, interpretation, or an acknowledgment of the terms of such 

agreements or related documents.

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 10 of 34
10

(i) Schedule E/F – Creditors Who Have Unsecured Claims. 

The Debtors have made reasonable efforts to report all priority and general 

unsecured claims against the Debtors on Schedule E/F based on the Debtors’ books 

and records as of the Petition Date. However, the actual value of claims against the 

Debtors may vary significantly from the represented liabilities. Certain claims on 

E/F may have been satisfied post-petition by the Debtors (including employee 

wages in the ordinary course) or third parties. Furthermore, accrued interest for 

some claims may not have been possible to determine. Parties in interest should 

not accept that the listed liabilities necessarily reflect the correct amount of any 

unsecured creditor’s allowed claims or the correct amount of all unsecured claims. 

Similarly, parties in interest should not anticipate that recoveries in these cases will 

reflect the relationship of the aggregate asset values and aggregate liabilities set 

forth in the Schedules. Parties in interest should consult their own professionals 

and advisors with respect to pursuing a claim. Although the Debtors and their 

professionals have generated financial information and data the Debtors believe to 

be reasonable, actual liabilities (and assets) may deviate significantly from the 

Schedules due to certain events that occur throughout these Chapter 11 Cases.

The claims listed on Schedule E/F arose or were incurred on various dates. In 

certain instances, the date on which a claim arose may be unknown or subject to 

dispute. Although reasonable efforts have been made to determine the date upon 

which claims listed in Schedule E/F were incurred or arose, updating that date for 

each claim in Schedule E/F would be unduly burdensome and cost-prohibitive and, 

therefore, the Debtors have not listed a date for each claim listed on Schedule E/F.

In the ordinary course of business, the Debtors generally receive invoices for goods 

and services after the delivery of such goods or services. As of the filing of the 

Schedules and Statements, the Debtors may not have received all invoices for 

payables, expenses, or liabilities that may have accrued before the Petition Date. 

Furthermore, payments to vendors and lienholders made subsequent to the filing of 

these Schedules will not be reflected in these Schedules. The Debtors reserve the 

right, but are not required, to amend Schedules E/F if they receive such invoices 

and/or make such payments. The claims of individual creditors are generally listed 

at the amounts recorded on the Debtors’ books and records and may not reflect all 

credits or allowances due from the creditor. The Debtors reserve all of their rights 

concerning credits or allowances.

Part 1 - Creditors with Priority Unsecured Claims. The Debtors included certain 

claims related to severance. The Debtors also included certain claims owing to 

various taxing authorities to which the Debtors may be liable. Priority unsecured 

tax claims are listed as contingent since they have been paid through first day relief. 

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 11 of 34
11

Moreover, the inclusion of any amounts owed to taxing authorities does not 

constitute an admission by the Debtors of such liability.

The Debtors reserve the right to assert that any claim listed on Schedule E/F does 

not constitute a priority claim under the Bankruptcy Code.

Part 2 - Creditors with Nonpriority Unsecured Claims. The Debtors have used 

reasonable efforts to report all general unsecured claims against the Debtors in 

Schedule E/F, Part 2, based upon the Debtors’ books and records as of the Petition 

Date. The Debtors made a reasonable attempt to set forth their unsecured 

obligations, although the actual amount of claims against the Debtors may vary 

from those liabilities represented on Schedule E/F, Part 2. The listed liabilities, 

which have been listed on a gross accounts payable basis, may not reflect the correct 

amount of any unsecured creditor’s allowed claims or the correct amount of all 

unsecured claims. 

Schedule E/F, Part 2, reflects certain prepetition amounts owing to counterparties 

to executory contracts and unexpired leases. Such prepetition amounts, however, 

may be paid in connection with the assumption or assumption and assignment of 

an executory contract or unexpired lease. Prepetition amounts that may be paid in 

accordance with court orders, are marked as contingent. In addition, Schedule E/F, 

Part 2, does not include claims that may arise in connection with the rejection of 

any executory contracts and unexpired leases, if any, that may be or have been 

rejected.

(j) Schedule G – Executory Contracts and Unexpired Leases. The Debtors hereby 

reserve all rights to dispute the validity, status, or enforceability of any contracts, 

agreements or leases set forth in Schedule G and to amend or supplement 

Schedule G as necessary. Additionally, the placing of a contract or lease onto 

Schedule G shall not be deemed an admission that such contract is an executory 

contract or unexpired lease, or that it is necessarily a binding, valid, and enforceable 

contract. Any and all of the Debtors’ rights, claims and causes of action with 

respect to the contracts and agreements listed on Schedule G are hereby reserved 

and preserved. In addition, the Debtors are continuing their review of all relevant 

documents and expressly reserve their right to amend all Schedules at a later time 

as necessary and/or to challenge the classification of any agreement as an executory 

contract or unexpired lease in any appropriate filing.

The names of employees and consultants and other individuals have been redacted 

for privacy purposes.

Certain information, such as the contact information or addresses of the 

counterparty, may not be included where such information could not be obtained 

using the Debtors’ reasonable efforts. Listing a contract or agreement on Schedule 

G does not constitute an admission that such contract or agreement is an executory 

contract or unexpired lease or that such contract or agreement was in effect on the 

Petition Date or is valid or enforceable. Expired contracts and leases may have also 

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 12 of 34
12

been inadvertently included. The Debtors hereby reserve all of their rights to 

dispute the validity, status, or enforceability of any contracts, agreements, or leases 

set forth in Schedule G and to amend or supplement such Schedule as necessary. 

Certain of the leases and contracts listed on Schedule G may contain renewal 

options, guarantees of payment, indemnifications, options to purchase, rights of 

first refusal and other miscellaneous rights. Such rights, powers, duties, and 

obligations are not set forth separately on Schedule G. In addition, the Debtors may 

have entered into various other types of agreements in the ordinary course of their 

business, such as supplemental agreements and letter agreements, which documents 

may not be set forth in Schedule G. The Debtors reserve the right to dispute the 

effectiveness of any such contract listed on Schedule G or to amend Schedule G at 

any time to remove any contract. 

The Debtors have reserved all rights to dispute or challenge the characterization of 

any transaction or any document or instrument related to a creditor’s claim. 

Although the Debtors have made diligent attempts to attribute an executory contract 

to its rightful Debtor, in certain instances, the Debtors may have inadvertently failed 

to do so due to the complexity and size of the Debtors’ businesses. Accordingly, 

the Debtors reserve all of its rights with respect to the named parties of any and all 

executory contracts, including the right to amend Schedule G. 

Omission of a contract or agreement from Schedule G does not constitute an 

admission that such omitted contract or agreement is not an executory contract or 

unexpired lease. The Debtors’ rights under the Bankruptcy Code with respect to 

any such omitted contract or agreement is not impaired by the omission. Certain 

Debtors are guarantors and parties to guaranty agreements regarding the Debtors’ 

prepetition credit facility. The guaranty obligations arising under these agreements 

are reflected on Schedules D and F only. 

11. Specific Statements Disclosures.

(a) Statements, Part 1, Question 1 – Gross Revenue from business. The Debtors 

recognize GAAP revenue in accordance with ASC Topic 606, Revenue from 

Contracts with Customers (“ASC 606”). Under ASC 606, an entity recognizes 

revenue when its customer obtains control of promised goods or services in an 

amount that reflects the consideration which the entity expects to receive in 

exchange for those goods or services. The Debtors recognize product revenue when 

a customer obtains control of the Debtors’ product, which occurs at a point in time, 

typically upon delivery to a customer as the delivery of the product is the only 

performance obligation. 

The product is distributed through an exclusive third-party logistics, or 3PL, 

distribution agent that does not take title to the product. The 3PL distributes 

Zokinvy to the customers, specialty pharmacies and specialty distributors 

(collectively referred to as “customers”), who then distribute the product to 

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 13 of 34
13

healthcare providers and patients. Taxes collected from the customer relating to 

product sales and remitted to governmental authorities are excluded from revenue. 

Revenues from product sales are recorded at the net sales price, or the transaction 

price, which includes estimates of variable consideration for which reserves are 

established and which result from discounts, returns, co-pay assistance, 

chargebacks, rebates, and other allowances that are offered within contracts 

between us and customers, healthcare providers and other indirect customers 

relating to the sale of Zokinvy. These reserves are based on the amounts earned or 

to be claimed on the related sales and are classified as reductions of accounts 

receivable or a current liability. Where appropriate, these estimates take into 

consideration a range of possible outcomes that are probability-weighted for 

relevant factors such as historical experience, current contractual and statutory 

requirements, specific known market events and trends, industry data and 

forecasted customer buying and payment patterns. Overall, these reserves reflect 

best estimates of the amount of consideration to which the Debtors are entitled 

based on the terms of the contract. 

The components of variable consideration related to product revenue were detailed 

in the Debtors’ Emergency Motion for Entry of Interim and Final Orders 

(I) Authorizing the Debtors to Honor and Continue Certain Customer Programs 

and Customer Obligations in the Ordinary Course of Business, and (II) Authorizing 

Banks to Honor and Process Checks and Electronic Transfer Requests Related 

Thereto [Docket No. 17] and are customary in the pharmaceutical industry. 

(b) Statements, Part 2, Question 4 – Payments and Transfers to Certain Insiders 

within 1 year before the filing. The Debtors reported payments to non-officer and 

officer insiders within the year prior to the Petition Date. Out of an abundance of 

caution, payments made to Alvarez & Marsal are reported both on Statements 

Question 4 and Question 11 due to the firm’s relationship to the Debtors as Chief 

Restructuring Officer. Payments made to Danforth Advisors LLC are also included 

out of an abundance of caution due to the Chief Financial Officer’s involvement 

with the company. Payments made to Eiger Group International, Inc. are also 

included out of an abundance of caution due to a former Director’s involvement 

with the company. The Debtors reserve all rights with respect to the determination 

or status of a person as an “insider” as defined in section 101(13) of the Bankruptcy 

Code.

(c) Statements, Part 3, Question 7 – Legal Actions or Assignments. The Debtors 

have made reasonable best efforts to identify all current pending litigation and legal 

proceedings involving the Debtors. The Debtors reserve all of their rights and 

defenses with respect to any and all listed lawsuits and legal proceedings. The 

listing of such suits and proceedings shall not constitute an admission by the 

Debtors of any liabilities or that the actions or proceedings were correctly filed 

against the Debtors.

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 14 of 34
14

(d) Statements, Part 4, Question 9 – Gifts or Charitable Contributions within 2 

years before the filing. Research grants are not considered in the context of this 

question. Research grants differ from a charitable contribution since both parties 

benefit. 

(e) Statements, Part 9, Question 16 – Collect and Retain personally identifiable 

information of customers. The Debtors collect a limited amount of information 

about customers. Examples of the types of information collected by the Debtors 

include, among other things, name, mailing address, telephone number, email and 

addresses.

Please see the Debtor’s privacy policy at https://www.eigerbio.com/privacypolicy/. 

(f) Statements, Part 9, Question 17– ERISA Plan as an Employee Benefit. The 

Debtors sponsor a 401(k) plan for their employees. 

(g) Statements, Part 10, Question 20 – Off-premises storage. The Debtors use 

certain third parties, including, for example, storage of product samples, raw 

materials, and finished goods. The Debtors perform inventory counts at Eiger to 

ensure accurate inventory records. 

(h) Statements, Part 13, Question 25 – Businesses in Which the Debtors Have an 

Interest. Eiger BioPharmaceuticals, Inc. has a 100% interest in EB Pharma LLC, 

Eiger BioPharmaceuticals Europe Limited, EBPI Merger Inc., and EigerBio Europe 

Limited.

(i) Statements, Part 13, Question 26 – Books, records, and financial statements. 

The Debtors’ common stock was publicly traded on the Nasdaq stock exchange. 

As of April 11, 2024, the Debtor’s common stock was suspended from trading. 

Prior to the suspension of trading on the Nasdaq, the Debtors reported their 

financial results directly to the U.S. Securities and Exchange Commission

(the “SEC”) for compliance with regulations. Because the SEC filings and the 

website are public record, the Debtors do not maintain records of the parties that 

requested or obtained copies of any of the SEC filings from the SEC or the debtors.

(j) Statements, Part 13, Question 27 – Inventories – Supervisor and Dates of 

Inventories Taken Within 2 years. The Debtors perform inventory counts of raw 

materials and finished goods inventories on an annual basis or as needed for 

operational reasons. The information included in response to Question 27 reflects 

the last five (5) inventory dates. 

(k) Statements, Part 13, Question 28 and 29 – Current and Former Officer and 

Directors. While the Debtors have made reasonable best efforts to list all 

applicable officers and directors for each Debtor in response to Statement Questions 

28 and 29, some may have been omitted. Disclosures relate specifically to 

terminated job titles or positions and are not indicative of the individuals’ current 

employment status with the Debtors. 

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 15 of 34
15

(l) Statements, Part 13, Question 30 – Payments, Distributions, or Withdrawals 

to Insiders. Refer to Statement Question 4 for this item.

* * * * *

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 16 of 34
 Fill in this information to identify the case:

Debtor name

United States Bankruptcy Court for the: 

Case number (If known):

Check if this is an 

amended filing

Eiger BioPharmaceuticals Europe Limited

Northern District of Texas, Dallas Division

24-80043 (SGJ)  ̈

Official Form 206Sum 

Summary of Assets and Liabilities for Non-Individuals 12/15

 $

 $

 $

 Part 1: Summary of Assets

1. Schedule A/B: Assets-Real and Personal Property (Official Form 206A/B)

1a. Real property:

Copy line 88 from Schedule A/B ................................................................................................................................

1b. Total personal property:

Copy line 91A from Schedule A/B ..............................................................................................................................

1c. Total of all property:

Copy line 92 from Schedule A/B ................................................................................................................................

0.00

Undetermined

Undetermined

 Part 2: Summary of Liabilities

 $

 $

 $

 $

2. Schedule D: Creditors Who Have Claims Secured by Property (Official Form 206D)

Copy the total dollar amount listed in Column A, Amount of claim, from line 3 of Schedule D ..........................................

3. Schedule E/F: Creditors Who Have Unsecured Claims (Official Form 206E/F)

3a. Total claim amounts of priority unsecured claims:

Copy the total claims from Part 1 from line 5a of Schedule E/F .................................................................................

3b. Total amount of claims of nonpriority amount of unsecured claims:

Copy the total of the amount of claims from Part 2 from line 5b of Schedule E/F .......................................................

4. Total liabilities ...............................................................................................................................................................

 Lines 2 + 3a + 3b

+

*Plus Undetermined Amounts

0.00

0.00

0.00

0.00

Official Form 206Sum Summary of Assets and Liabilities for Non-Individuals page 1

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 17 of 34
 ̈

24-80043 (SGJ)

Northern District of Texas, Dallas Division

Check if this is an 

Case number (If known) amended filing

United States Bankruptcy Court for the: 

Debtor name

 Fill in this information to identify the case:

Eiger BioPharmaceuticals Europe Limited

Schedule A/B: Assets - Real and Personal Property 12/15

For Part 1 through Part 11, list each asset under the appropriate category or attach separate supporting schedules, such as a fixed asset schedule or 

depreciation schedule, that gives the details for each asset in a particular category. List each asset only once. In valuing the debtor’s interest, do not deduct 

the value of secured claims. See the instructions to understand the terms used in this form.

Disclose all property, real and personal, which the debtor owns or in which the debtor has any other legal, equitable, or future interest. Include all property in 

which the debtor holds rights and powers exercisable for the debtor's own benefit. Also include assets and properties which have no book value, such as fully 

depreciated assets or assets that were not capitalized. In Schedule A/B, list any executory contracts or unexpired leases. Also list them on Schedule G: 

Executory Contracts and Unexpired Leases (Official Form 206G).

Be as complete and accurate as possible. If more space is needed, attach a separate sheet to this form. At the top of any pages added, write the debtor’s 

name and case number (if known). Also identify the form and line number to which the additional information applies. If an additional sheet is attached, 

include the amounts from the attachment in the total for the pertinent part.

Official Form 206A/B

 $

þ

 ̈

 ̈

þ

 $

 $

7.2

7.1

Description, including name of holder of deposit

 Current value of debtor's

 interest Yes. Fill in the information below.

 No.Go to Part 3.

7. Deposits, including security deposits and utility deposits

6. Does the debtor have any deposits or prepayments?

 Part 2: Deposits and prepayments

 $

 $

 $

 $

 $

Add lines 2 through 4 (including amounts on any additional sheets). Copy the total to line 80.

5. Total of Part 1

4.2

4.1

4. Other cash equivalents (Identify all)

3.2

3.1

Name of institution (bank or brokerage firm) Type of account Last 4 digits of account number

3. Checking, savings, money market, or financial brokerage accounts (Identify all)

 Current value of debtor's

 interest

2. Cash on hand

 All cash or cash equivalents owned or controlled by the debtor

 Yes. Fill in the information below.

 No. Go to Part 2.

1. Does the debtor have any cash or cash equivalents?

 Part 1: Cash and cash equivalents

0.00

Official Form 206A/B Schedule A/B: Assets - Real and Personal Property Page 1

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 18 of 34
Debtor Eiger BioPharmaceuticals Europe Limited Case number (If known) 24-80043 (SGJ)

Name

 $

 $

 Current value of debtor's 

 interest

 $

 $

8. Prepayments, including prepayments on executory contracts, leases, insurance, taxes, and rent

Description, including name of holder of prepayment

8.1

8.2

9. Total of Part 2.

Add lines 7 through 8. Copy the total to line 81. $

 Part 3: Accounts receivable

10. Does the debtor have any accounts receivable?

 Yes. Fill in the information below.

 No. Go to Part 4.

 Current value of debtor's 

 interest

11. Accounts receivable

11a. 90 days old or less: 

11b. Over 90 days old:

=

=

......

......

12. Total of Part 3

Current value on lines 11a + 11b = line 12. Copy the total to line 82.

 Part 4: Investments

13. Does the debtor own any investments?

14. Mutual funds or publicly traded stocks not included in Part 1

15. Non-publicly traded stock and interests in incorporated and unincorporated businesses, 

 including any interest in an LLC, partnership, or joint venture

16. Government bonds, corporate bonds, and other negotiable and non-negotiable 

 instruments not included in Part 1 

17. Total of Part 4

 Yes. Fill in the information below.

 No. Go to Part 5.

 $

 Valuation method 

 used for current value

face amount

face amount

doubtful or uncollectible accounts

doubtful or uncollectible accounts

Name of fund or stock:

14.2

 $

 $

15.2

15.1 $

 $

Name of entity: % of ownership:

%

%

Describe:

16.2

16.1

14.1

 $

 $

 $

Add lines 14 through 16. Copy the total to line 83.

þ

 ̈

þ

 ̈

0.00

0.00

0.00

Official Form 206A/B Schedule A/B: Assets - Real and Personal Property Page 2

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 19 of 34
Debtor Eiger BioPharmaceuticals Europe Limited Case number (If known) 24-80043 (SGJ)

Name

 $ $

 $

 $

 $

 $

 $

 $ $

 $

 $

 $

 $

23. Total of Part 5.

 Add lines 19 through 22. Copy the total to line 84.

 $

 Part 5: Inventory, excluding agriculture assets

18. Does the debtor own any inventory (excluding agriculture assets)?

 Yes. Fill in the information below.

 No. Go to Part 6.

24. Is any of the property listed in Part 5 perishable?

26. Has any of the property listed in Part 5 been appraised by a professional within the last year?

 Yes. Book value

 No

þ

 ̈

 General Description Date of the last

 physical inventory

 Net book value of

 debtor's interest

 (Where available)

 Valuation method 

 used for current 

 value

 Current value of 

 debtor's interest

19. Raw materials

20. Work in progress

21. Finished goods, including goods held for resale

22. Other inventory or supplies

 $

 $

MM / DD / YYYY

MM / DD / YYYY

MM / DD / YYYY

MM / DD / YYYY

25. Has any of the property listed in Part 5 been purchased within 20 days before the bankruptcy was filed?

 ̈

þ No

 Yes

 ̈

 ̈

 No

 Yes

þ

 ̈

 Valuation method Current value

 Part 6: Farming and fishing-related assets (other than titled motor vehicles and land) 

27. Does the debtor own or lease any farming and fishing-related assets (other than titled motor vehicles and land)?

 Yes. Fill in the information below.

þ No. Go to Part 7. 

 ̈

 General Description Net book value of

 debtor's interest

 (Where available)

 Valuation method

 used for current 

 value

 Current value of debtor's

 interest

0.00

28. Crops-either planted or harvested

29. Farm animals Examples: Livestock, poultry, farm-raised fish

30. Farm machinery and equipment (Other than titled motor vehicles)

31. Farm and fishing supplies, chemicals, and feed

32. Other farming and fishing-related property not already listed in Part 6 

 $

 $

 $

 $

 $

Official Form 206A/B Schedule A/B: Assets - Real and Personal Property Page 3

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 20 of 34
Debtor Eiger BioPharmaceuticals Europe Limited Case number (If known) 24-80043 (SGJ)

Name

 $ $

 $

 $

 $

 $

 $

 $

 $

 $

 $

33. Total of Part 6.

 Yes. Is any of the debtor’s property stored at the cooperative?

 No

 Yes. Book value

 No

þ

 ̈

39. Office furniture

40. Office fixtures

41. Office equipment, including all computer equipment and

 communication systems equipment and software

42. Collectibles Examples: Antiques and figurines; paintings, prints, or other

 artwork; books, pictures, or other art objects; china and crystal; stamp, coin,

 or baseball card collections; other collections, memorabilia, or collectibles

 ̈

 ̈ No

 Yes

 ̈

 ̈

 No

 Yes

þ

 ̈

Valuation method Current value

 Part 7: Office furniture, fixtures, and equipment; and collectibles

38 Does the debtor own or lease any office furniture, fixtures, equipment, or collectibles?

 Yes. Fill in the information below.

þ No. Go to Part 8. 

 ̈

 General Description Net book value of

 debtor's interest

 (Where available)

 Valuation method 

 used for current

 value

 Current value of debtor's

 interest

42.1

42.2

42.3

43. Total of Part 7.

44. Is a depreciation schedule available for any of the property listed in Part 7? 

 $

 $

 $

 Add lines 28 through 32. Copy the total to line 85. $ 0.00

34. Is the debtor a member of an agricultural cooperative?

35. Has any of the property listed in Part 6 been purchased within 20 days before the bankruptcy was filed? 

36. Is a depreciation schedule available for any of the property listed in Part 6?

37. Has any of the property listed in Part 6 been appraised by a professional within the last year?

þ

 ̈

 No

 Yes

 Add lines 39 through 42. Copy the total to line 86. $ 0.00

 Yes

þ No 

 ̈

45. Has any of the property listed in Part 7 been appraised by a professional within the last year?

 No 

 Yes

þ

 ̈

Official Form 206A/B Schedule A/B: Assets - Real and Personal Property Page 4

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 21 of 34
Debtor Eiger BioPharmaceuticals Europe Limited Case number (If known) 24-80043 (SGJ)

Name

 $

 $

 $

 $

 $

 $

 $

 $

 $

 $ $

 $

 $

 $

 $

51. Total of Part 8.

 Add lines 47 through 50. Copy the total to line 87. 

 $

 Part 8: Machinery, equipment, and vehicles

46. Does the debtor own or lease any machinery, equipment, or vehicles?

 Yes. Fill in the information below.

 No. Go to Part 9.

49. Aircraft and accessories

52. Is a depreciation schedule available for any of the property listed in Part 8?

þ

 ̈

 General Description

 Include year, make, model, and identification numbers (i.e., VIN,

 HIN, or N-number)

 Net book value of

 debtor's interest

 (Where available)

 Valuation method

 used for current

 value

 Current value of debtor's

 interest

47. Automobiles, vans, trucks, motorcycles, trailers, and titled farm vehicles

 $

 $

50. Other machinery, fixtures, and equipment (excluding farm

 machinery and equipment)

 No

 Yes

þ

 ̈

53. Has any of the property listed in Part 8 been appraised by a professional within the last year? 

 Yes

þ No

 ̈

47.1

47.2

47.3

47.4

48. Watercraft, trailers, motors, and related accessories Examples: Boats, 

 trailers, motors, floating homes, personal watercraft, and fishing vessels

48.1

48.2

49.1

49.2

 $

0.00

Official Form 206A/B Schedule A/B: Assets - Real and Personal Property Page 5

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 22 of 34
Debtor Eiger BioPharmaceuticals Europe Limited Case number (If known) 24-80043 (SGJ)

Name

 $ $

 Intangibles and intellectual property 

 $

 $ $

 $

 $

 $

 $

 $

 $

 $

 $ $

 $

 $

 $

 $

56. Total of Part 9.

 Add the current value on lines 55.1 through 55.6 and entries from any additional sheets. Copy the total to line 88.

 $

 Part 9: Real property

54. Does the debtor own or lease any real property?

Yes. Fill in the information below.

No. Go to Part 10.

58. Has any of the property listed in Part 9 been appraised by a professional within the last year?

Yes

No

þ

 ̈

 Description and location of property

Include street address or other description such as

 Assessor Parcel Number (APN), and type of property

 (for example, acreage, factory, warehouse, apartment

 or office building), if available.

Nature and extent

of debtor’s interest

in property

 Net book value of

 debtor's interest

 (Where available)

 Valuation method

 used for current

 value

 Current value of 

 debtor's interest

57. Is a depreciation schedule available for any of the property listed in Part 9?

þ

 ̈

No

Yes

þ

 ̈

Part 10:

59. Does the debtor have any interests in intangibles or intellectual property?

 Yes. Fill in the information below.

þ No. Go to Part 11. 

 ̈

 General Description Net book value of

 debtor's interest

 (Where available)

 Valuation method

 used for current

 value

 Current value of debtor's

 interest

60. Patents, copyrights, trademarks, and trade secrets

61. Internet domain names and websites

62. Licenses, franchises, and royalties 

63. Customer lists, mailing lists, or other compilations 

64. Other intangibles, or intellectual property

 $

 $

 $

 $

 $

55. Any building, other improved real estate, or land which the debtor owns or in which the debtor has an interest

55.1

55.2

55.3

55.4

55.5

55.6 $

0.00

65. Goodwill

66. Total of Part 10.

 Add lines 60 through 65. Copy the total to line 89.

 $ 0.00

Official Form 206A/B Schedule A/B: Assets - Real and Personal Property Page 6

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 23 of 34
Debtor Eiger BioPharmaceuticals Europe Limited Case number (If known) 24-80043 (SGJ)

Name

None

None

None

None

$

None

$

None

 $

 $

 $

 All other assets 

 $

67. Do your lists or records include personally identifiable information of customers (as defined in 11 U.S.C. §§ 101(41A) and 107)?

Yes

No

69. Has any of the property listed in Part 10 been appraised by a professional within the last year?

Yes

No

þ

 ̈

68. Is there an amortization or other similar schedule available for any of the property listed in Part 10?

þ

 ̈

No

Yes

þ

 ̈

Part 11:

70. Does the debtor own any other assets that have not yet been reported on this form?

Yes. Fill in the information below.

 ̈ No. Go to Part 12. 

þ

71. Notes receivable

Nature of Claim

0.00

78. Total of Part 11.

 Add lines 71 through 77. Copy the total to line 90.

 $

 Include all interests in executory contracts and unexpired leases not previously reported on this form. 

 Description (include name of obligor) 

 Current value of 

 debtor's interest

=

Total Face Amount Doubtful or uncollectible Amount

72. Tax refunds and unused net operating losses (NOLs)

 Description (for example, federal, state, local) 

 $

 $

 $

Tax Year

Tax Year

Tax Year

0.00

73. Interests in insurance policies or annuities

Undetermined

74. Causes of action against third parties (whether or not a lawsuit

 has been filed)

 $

Amount Requested

75. Other contingent and unliquidated claims or causes of action of

 every nature, including counterclaims of the debtor and rights to

 set off claims

Nature of Claim

Amount Requested

 $

76. Trusts, equitable or future interests in property

 $ 0.00

77. Other property of any kind not already listed Examples: Season tickets,

 country club membership

0.00

79. Has any of the property listed in Part 11 been appraised by a professional within the last year?

þ

 ̈ Yes

No

Undetermined

0.00

0.00

*Plus Undetermined Amounts

Official Form 206A/B Schedule A/B: Assets - Real and Personal Property Page 7

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 24 of 34
Debtor Eiger BioPharmaceuticals Europe Limited Case number (If known) 24-80043 (SGJ)

Name

 $

 $0.00

80. Cash, cash equivalents, and financial assets. Copy line 5, Part 1.

 Copy line 43, Part 7.

 Part 12: Summary

In Part 12 copy all of the totals from the earlier parts of the form.

 Type of Property Current value of

 personal property

Current value 

of real property

92. Total of all property on Schedule A/B. Lines 91a + 91b = 92................................................................................................

81. Deposits and prepayments. Copy line 9, Part 2.

82. Accounts receivable. Copy line 12, Part 3.

83. Investments. Copy line 17, Part 4.

84. Inventory. Copy line 23, Part 5.

85. Farming and fishing-related assets. Copy line 33, Part 6.

86. Office furniture, fixtures, and equipment; and collectibles.

87. Machinery, equipment, and vehicles. Copy line 51, Part 8.

88. Real property. Copy line 56, Part 9. . ...............................................................................

89. Intangibles and intellectual property. Copy line 66, Part 10.

90. All other assets. Copy line 78, Part 11.

91. Total. Add lines 80 through 90 for each column..............................91a.

 $

 $

 $

 $

 $

 $

 $

 $

 $

 $

 $

 $0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

Undetermined

Undetermined

Undetermined

+ 91b.

*Plus Undetermined Amounts

Official Form 206A/B Schedule A/B: Assets - Real and Personal Property Page 8

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 25 of 34
 Fill in this information to identify the case:

Debtor name

United States Bankruptcy Court for the: 

Case number (If known):

Check if this is an 

amended filing

Eiger BioPharmaceuticals Europe Limited

Northern District of Texas, Dallas Division

24-80043 (SGJ)

 ̈

Official Form 206D 

Schedule D: Creditors Who Have Claims Secured by Property

Be as complete and accurate as possible.

þ

1. Do any creditors have claims secured by debtor's property?

No. Check this box and submit page 1 of this form to the court with debtor’s other schedules. Debtor has nothing else to report on this form. 

 ̈ Yes. Fill in all of the information below. 

12/15

Part 1: List Creditors Who Have Secured Claims 

 2. List in alphabetical order all creditors who have secured claims. If a creditor has more than one

 secured claim, list the creditor separately for each claim. 

Column A

 Amount of Claim

 Do not deduct the value

 of collateral.

Column B

 Value of collateral

 that supports this

 claim

Creditor's name Describe debtor’s property that is subject to a lien

Creditor's mailing address

Creditor's email address, if known

Date debt was incurred

Last 4 digits of account

number

Do multiple creditors have an interest in the 

same property?

No

Yes. Specify each creditor, including this 

creditor, and its relative priority.

$ $

Describe the lien

Is the creditor an insider or related party?

Is anyone else liable on this claim?

No

No

Yes

Yes. Fill out Schedule H: Codebtors (Official Form 206H).

As of the petition filing date, the claim is:

Check all that apply.

Contingent

Unliquidated

Disputed

 ̈

 ̈

 ̈

 ̈

 ̈

 ̈

 ̈

 ̈

 ̈

 ̈

 ̈

Creditor's name Describe debtor’s property that is subject to a lien

Creditor's mailing address

Creditor's email address, if known

Date debt was incurred

Last 4 digits of account

number

Do multiple creditors have an interest in the 

same property?

No

Yes. Have you already specified the relative 

priority?

No. Specify each creditor, including this

 creditor, and its relative priority. 

Yes. The relative priority of creditors is

 specified on lines 

Describe the lien

Is the creditor an insider or related party?

Is anyone else liable on this claim?

No

Yes

No

Yes. Fill out Schedule H: Codebtors (Official Form 206H).

As of the petition filing date, the claim is:

Check all that apply.

Contingent

Unliquidated

Disputed

$ $

 ̈

 ̈

 ̈

 ̈

 ̈

 ̈

 ̈

 ̈

 ̈

 3. Total of the dollar amounts from Part 1, Column A, including the amounts from the Additional Page, if any. $

Official Form 206D Schedule D: Creditors Who Have Claims Secured by Property Page 1 of 2

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 26 of 34
Debtor Eiger BioPharmaceuticals Europe Limited

Name

Case number (If known): 24-80043 (SGJ)

Part 2: List Others to Be Notified for a Debt Already Listed in Part 1

 List in alphabetical order any others who must be notified for a debt already listed in Part 1. Examples of entities that may be listed are collection

 agencies, assignees of claims listed above, and attorneys for secured creditors.

 If no others need to be notified for the debts listed in Part 1, do not fill out or submit this page. If additional pages are needed, copy this page.

 Name and address

 On which line in Part 1

 did you enter the

 related creditor?

 Last 4 digits of

 account number

 for this entity

Line 2.

Line 2.

Line 2.

Line 2.

Line 2.

Line 2.

Line 2.

Line 2.

Line 2.

Line 2.

Line 2.

Official Form 206D Official Part 2 of Schedule D: Creditors Who Have Claims Secured by Property Page 2 of 2

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 27 of 34
Eiger BioPharmaceuticals Europe Limited

 Fill in this information to identify the case:

Debtor

United States Bankruptcy Court for the: 

Case number

 (If known)

Check if this is an 

amended filing

Northern District of Texas, Dallas Division

24-80043 (SGJ)

 ̈

Official Form 206E/F

Schedule E/F: Creditors Who Have Unsecured Claims

Be as complete and accurate as possible. Use Part 1 for creditors with PRIORITY unsecured claims and Part 2 for creditors with NONPRIORITY unsecured 

claims. List the other party to any executory contracts or unexpired leases that could result in a claim. Also list executory contracts on Schedule A/B: Assets - 

Real and Personal Property (Official Form 206A/B) and on Schedule G: Executory Contracts and Unexpired Leases (Official Form 206G). Number the 

entries in Parts 1 and 2 in the boxes on the left. If more space is needed for Part 1 or Part 2, fill out and attach the Additional Page of that Part included in this 

form. 

12/15

 Part 1: List All Creditors with PRIORITY Unsecured Claims

1. Do any creditors have priority unsecured claims? (See 11 U.S.C. § 507).

 No. Go to Part 2.

 Yes. Go to line 2.

2. List in alphabetical order all creditors who have unsecured claims that are entitled to priority in whole or in part. If the debtor has more 

 than 3 creditors with priority unsecured claims, fill out and attach the Additional Page of Part 1.

 Total claim Priority amount

þ

 ̈

Basis for the claim: 

$

SpecifyCode subsection of PRIORITY unsecured 

claim: 11 U.S.C. § 507(a) ()

Last 4 digits of account

number

2.1 Priority creditor’s name and mailing address As of the petition filing date, the claim is: $

Date or dates debt was incurred

No

Yes

Contingent

Unliquidated

Disputed

Check all that apply.

Is the claim subject to offset?

 ̈

 ̈

 ̈

 ̈

 ̈

Basis for the claim: 

$

SpecifyCode subsection of PRIORITY unsecured 

claim: 11 U.S.C. § 507(a) ()

Last 4 digits of account

number

2.2 Priority creditor’s name and mailing address As of the petition filing date, the claim is: $

Date or dates debt was incurred

No

Yes

Contingent

Unliquidated

Disputed

Check all that apply.

Is the claim subject to offset?

 ̈

 ̈

 ̈

 ̈

 ̈

Basis for the claim: 

$

SpecifyCode subsection of PRIORITY unsecured 

claim: 11 U.S.C. § 507(a) ()

Last 4 digits of account

number

2.3 Priority creditor’s name and mailing address As of the petition filing date, the claim is: $

Date or dates debt was incurred

No

Yes

Contingent

Unliquidated

Disputed

Check all that apply.

Is the claim subject to offset?

 ̈

 ̈

 ̈

 ̈

 ̈

Official Form 206E/F Schedule E/F: Creditors Who Have Unsecured Claims Page 1 of 4

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 28 of 34
Debtor Eiger BioPharmaceuticals Europe Limited Case number (If known) 24-80043 (SGJ)

Name

 Part 2: List All Creditors with NONPRIORITY Unsecured Claims 

3. List in alphabetical order all of the creditors with nonpriority unsecured claims. If the debtor has more than 6 creditors with nonpriority

 unsecured claims, fill out and attach the Additional Page of Part 2.

 Amount of claim

Basis for the claim: 

3.1 Nonpriority creditor’s name and mailing address As of the petition filing date, the claim is:

 $

Date or dates debt was incurred

Check all that apply.

Contingent

Unliquidated

Disputed

Is the claim subject to offset?

No

Yes

 ̈

 ̈

 ̈

 ̈

 ̈

Last 4 digits of account number

Basis for the claim: 

3.2 Nonpriority creditor’s name and mailing address As of the petition filing date, the claim is:

 $

Date or dates debt was incurred

Check all that apply.

Contingent

Unliquidated

Disputed

Is the claim subject to offset?

No

Yes

 ̈

 ̈

 ̈

 ̈

 ̈

Last 4 digits of account number

Basis for the claim: 

3.3 Nonpriority creditor’s name and mailing address As of the petition filing date, the claim is:

 $

Date or dates debt was incurred

Check all that apply.

Contingent

Unliquidated

Disputed

Is the claim subject to offset?

No

Yes

 ̈

 ̈

 ̈

 ̈

 ̈

Last 4 digits of account number

Basis for the claim: 

3.4 Nonpriority creditor’s name and mailing address As of the petition filing date, the claim is:

 $

Date or dates debt was incurred

Check all that apply.

Contingent

Unliquidated

Disputed

Is the claim subject to offset?

No

Yes

 ̈

 ̈

 ̈

 ̈

 ̈

Last 4 digits of account number

Basis for the claim: 

3.5 Nonpriority creditor’s name and mailing address As of the petition filing date, the claim is:

 $

Date or dates debt was incurred

Check all that apply.

Contingent

Unliquidated

Disputed

Is the claim subject to offset?

No

Yes

 ̈

 ̈

 ̈

 ̈

 ̈

Last 4 digits of account number

Basis for the claim: 

3.6 Nonpriority creditor’s name and mailing address As of the petition filing date, the claim is:

 $

Date or dates debt was incurred

Check all that apply.

Contingent

Unliquidated

Disputed

Is the claim subject to offset?

No

Yes

 ̈

 ̈

 ̈

 ̈

 ̈

Last 4 digits of account number

Official Form 206E/F Schedule E/F: Creditors Who Have Unsecured Claims Page 2 of 4

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 29 of 34
Debtor Eiger BioPharmaceuticals Europe Limited

Name

Case number (If known): 24-80043 (SGJ)

 Part 3: List Others to Be Notified About Unsecured Claims

4. List in alphabetical order any others who must be notified for claims listed in Parts 1 and 2. Examples of entities that may be listed are collection agencies,

 assignees of claims listed above, and attorneys for unsecured creditors.

 If no others need to be notified for the debts listed in Parts 1 and 2, do not fill out or submit this page. If additional pages are needed, copy the next page.

 Name and mailing address On which line in Part 1 or Part 2 is the

 related creditor (if any) listed?

 Last 4 digits of

 account number, if 

 any

4.1 Line

 ̈ Not listed. Explain 

4.2 Line

 ̈ Not listed. Explain 

4.3 Line

 ̈ Not listed. Explain 

4.4 Line

 ̈ Not listed. Explain 

4.5 Line

 ̈ Not listed. Explain 

4.6 Line

 ̈ Not listed. Explain 

4.7 Line

 ̈ Not listed. Explain 

4.8 Line

 ̈ Not listed. Explain 

4.9 Line

 ̈ Not listed. Explain 

Official Form 206E/F Schedule E/F: Creditors Who Have Unsecured Claims Page 3 of 4

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 30 of 34
Debtor Eiger BioPharmaceuticals Europe Limited

Name

Case number (If known) 24-80043 (SGJ)

 Part 4: Total Amounts of the Priority and Nonpriority Unsecured Claims

$

$

$

Add the amounts of priority and nonpriority unsecured claims.

 Total of claim amounts

5a.

5b.

5c.

Total claims from Part 1 

Total claims from Part 2

Total of Parts 1 and 2

Lines 5a + 5b = 5c.

5.

5a.

5b.

5c.

 0.00

 0.00

 0.00

+

Official Form 206E/F Schedule E/F: Creditors Who Have Unsecured Claims Page 4 of 4

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 31 of 34
 Fill in this information to identify the case:

Debtor name

United States Bankruptcy Court for the: 

Case number (If known):

Check if this is an 

amended filing

Eiger BioPharmaceuticals Europe Limited

Northern District of Texas, Dallas Division

24-80043 (SGJ)

 ̈

Official Form 206G

Schedule G: Executory Contracts and Unexpired Leases

Be as complete and accurate as possible. If more space is needed, copy and attach the additional page, numbering the entries consecutively.

12/15

Yes. Fill in all of the information below even if the contracts or leases are listed on Schedule A/B: Assets - Real and Personal Property (Official 

Form 206A/B).

 2. List all contracts and unexpired leases

 1. Does the debtor have any executory contracts or unexpired leases?

No. Check this box and file this form with the court with the debtor’s other schedules. There is nothing else to report on this form.

 State the name and mailing address for all other parties with

 whom the debtor has an executory contract or unexpired lease

 ̈

þ

2.1

State what the contract or 

lease is for and the nature

of the debtor’s interest 

State the term remaining

List the contract number of

any government contract

MENZIES LLP

HEATHROW BUSINESS CENTRE

65 HIGH STREET

EGHAM, TW20 9EY

UNITED KINGDOM

Letter Agreement

2.2

State what the contract or 

lease is for and the nature

of the debtor’s interest 

State the term remaining

List the contract number of

any government contract

TRAVELERS PROPERTY CASUALTY COMPANY OF AMERICA

ONE TOWER SQUARE, 2GSA

HARTFORD, CT 06183

Commercial Package Policy - Effective 

as of 11/18/2023

2.3

State what the contract or 

lease is for and the nature

of the debtor’s interest 

State the term remaining

List the contract number of

any government contract

XL INSURANCE COMPANY SE (IRISH BRANCH)

FINANCIAL LINES CLAIMS MANAGER

8 ST. STEPHEN'S GREEN

DUBLIN 2, D02 VK30

IRELAND (EIRE)

Commercial Management Liability 

Insurance - Effective as of 3/22/2023

State what the contract or 

lease is for and the nature

of the debtor’s interest 

State the term remaining

List the contract number of

any government contract

State what the contract or 

lease is for and the nature

of the debtor’s interest 

State the term remaining

List the contract number of

any government contract

Official Form 206G Schedule G: Executory Contracts and Unexpired Leases Page 1 of 1

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 32 of 34
 Fill in this information to identify the case:

Debtor name

United States Bankruptcy Court for the: 

Case number (If known):

Check if this is an 

amended filing

Eiger BioPharmaceuticals Europe Limited

Northern District of Texas, Dallas Division

24-80043 (SGJ)

 ̈

Official Form 206H 

Schedule H: Codebtors

Be as complete and accurate as possible. If more space is needed, copy the Additional Page, numbering the entries consecutively. Attach the 

additional Page to this page.

12/15

 1. Does the debtor have any codebtors?

þ No. Check this box and submit this form to the court with the debtor's other schedules. Nothing else needs to be reported on this form.

Yes

 2. In Column 1, list as codebtors all of the people or entities who are also liable for any debts listed by the debtor in the schedules of

 creditors, Schedules D-G. Include all guarantors and co-obligors. In Column 2, identify the creditor to whom the debt is owed and each

 schedule on which the creditor is listed. If the codebtor is liable on a debt to more than one creditor, list each creditor separately in Column 2.

 Column 1: Codebtor Column 2: Creditor

 Check all schedules

 that apply: Name Mailing address Name

 ̈

2.1 D

E/F

G

 ̈

 ̈

 ̈

2.2 D

E/F

G

 ̈

 ̈

 ̈

2.3 D

E/F

G

 ̈

 ̈

 ̈

2.4 D

E/F

G

 ̈

 ̈

 ̈

2.5 D

E/F

G

 ̈

 ̈

 ̈

2.6 D

E/F

G

 ̈

 ̈

 ̈

Official Form 206H Schedule H: Codebtors Page 1 of 1

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 33 of 34
Eiger BioPharmaceuticals Europe Limited

 Fill in this information to identify the case and this filing:

Debtor name

United States Bankruptcy Court for the: 

Case number (If known)

Northern District of Texas, Dallas Division

24-80043 (SGJ)

Official Form 202

Declaration Under Penalty of Perjury for Non-Individual Debtors

An individual who is authorized to act on behalf of a non-individual debtor, such as a corporation or partnership, must sign and submit this form for the 

schedules of assets and liabilities, any other document that requires a declaration that is not included in the document, and any amendments of those 

documents. This form must state the individual’s position or relationship to the debtor, the identity of the document, and the date. Bankruptcy Rules 1008 

and 9011.

WARNING -- Bankruptcy fraud is a serious crime. Making a false statement, concealing property, or obtaining money or property by fraud in connection 

with a bankruptcy case can result in fines up to $500,000 or imprisonment for up to 20 years, or both. 18 U.S.C. §§ 152, 1341, 1519, and 3571.

12/15

 Declaration and signature

I am the president, another officer, or an authorized agent of the corporation; a member or an authorized agent of the partnership; or

another individual serving as a representative of the debtor in this case.

I declare under penalty of perjury that the foregoing is true and correct.

Executed on X

Position or relationship to debtor

I have examined the information in the documents checked below and I have a reasonable belief that the information is true and correct:

þ Schedule A/B: Assets-Real and Personal Property (Official Form 206A/B)

 Schedule D: Creditors Who Have Claims Secured by Property (Official Form 206D)

 Schedule E/F: Creditors Who Have Unsecured Claims (Official Form 206E/F)

 Schedule G: Executory Contracts and Unexpired Leases (Official Form 206G)

 Schedule H: Codebtors (Official Form 206H)

 Summary of Assets and Liabilities for Non-Individuals (Official Form 206Sum) 

 Amended Schedule

 Chapter 11 or Chapter 9 Cases: List of Creditors Who Have the 20 Largest Unsecured Claims and Are Not Insiders (Official Form 204)

 Other document that requires a declaration

MM / DD / YYYY Signature of individual signing on behalf of debtor

Printed name

þ

þ

þ

þ

þ

 ̈

 ̈

 ̈

05/06/2024

 Douglas Staut

 Chief Restructuring Officer

/s/ Douglas Staut

Official Form 202 Declaration Under Penalty of Perjury for Non-Individual Debtors

Case 24-80043-sgj11 Doc 8 Filed 05/06/24 Entered 05/06/24 23:45:29 Desc Main

Document Page 34 of 34